24 May 2013
Keywords: novartis, withdraws, eu, label, extension, zometa, swiss
Article | 26 November 2007
Swiss drug major Novartis has withdrawn its application to extend the marketing authorization application to include a new indication for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 November 2007
23 May 2013
© 2013 thepharmaletter.com